Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Gender influence on schizophrenia-relevant abnormalities in a cuprizone demyelination model.
Enhanced patient support services improve patient persistence with multiple sclerosis treatment.
Influence of Cognitive Function on Speech and Articulation Rate in Multiple Sclerosis.
Overexpression of CD44 in Neural Precursor Cells Improves Trans- Endothelial Migration and Facilitates Their Invasion of Perivascular Tissues In Vivo.
[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
[Adaptative immunity and pathophysiology of multiple sclerosis.]
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study.
Weight status in persons with multiple sclerosis: implications for mobility outcomes.
Multiple sclerosis: Preventing progression and disability in MS-when to treat?
TNF-alpha promotes cerebral pericyte remodeling in vitro, via a switch from alpha1 to alpha2 integrins.
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Multiple sclerosis: Severity of cognitive deficits in MS linked to disease course.
Longitudinal associations between MRI and cognitive changes in very early MS.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Multiple sclerosis guideline production takes off.
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
Temporal expression of growth factors triggered by epiregulin regulates inflammation development.
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Multiple sclerosis treatment: risk mitigation.
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments.
Treatment Against Human Endogenous Retrovirus: A Possible Personalized Medicine Approach for Multiple Sclerosis.
The poor recovery of neuromyelitis optica spectrum disorder is associated with a lower level of CXCL12 in the human brain.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
Internal jugular vein blood flow in multiple sclerosis patients and matched controls.
Pages
« first
‹ previous
…
521
522
523
524
525
526
527
528
529
…
next ›
last »